Pfizer says its experimental pill designed to fight Covid-19 reduced the risk of hospitalization and death for high-risk patients by about 89%
The company hopes it can eventually offer the pill, given in combination with an older antiviral drug called ritonavir, to people to take at home before they get sick enough to go to the hospital.A so-called interim analysis -- done before the trial was scheduled to end -- showed an 89% reduction in the risk of hospitalization or death from Covid-19 if patients got it soon enough, the company said.
People can also be treated with monoclonal antibodies, which are injected or infused therapies that kickstart the immune system to help fight off infection. They are not as easy to take as a pill and must be administered by a trained professional.Merck is seeking FDA emergency use authorization for molnupiravir, an antiviral capsule people could take at home. It's been shown to reduce the risk of hospitalization or death by about 50%.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Pfizer COVID-19 vaccine now available for kids ages 5 to 11: 5 things to knowAn 8-year-old receives his vaccine—and gets a hug from Dr. Bear—at a Washington hospital. What to know as the Pfizer COVID-19 vaccine is now available for kids ages 5 to 11:
続きを読む »
New COVID-19 pill cut hospital, death risk by 90%WASHINGTON (AP) — Pfizer Inc. said Friday that its experimental antiviral pill for COVID-19 cut rates of hospitalization and death by nearly 90% as the drugmaker joins the race to bring the first easy-to-use medication against the coronavirus to the U.S.
続きを読む »
Inside the World’s Most Blatant Covid-19 Coverup: Secret Burials, a Dead PresidentTanzania denied the existence of the pandemic for months, even as thousands likely died. The country is a clue to its hidden global toll; “This is one of the government’s coronavirus cemeteries, but we’re not allowed to call it that.”
続きを読む »
Opinion | Covid-19 Boosters Aren’t for EveryoneFrom WSJopinion: Healthy people in their 20s have been asking me about getting the third shot of the Covid-19 mRNA vaccines, recently authorized for older people. I’ve advised caution, writes Michael Segal. More vaccine isn’t always better.
続きを読む »
What parents need to know about COVID-19 rapid testingFrom where to buy them to when to use them—and how useful they are in the first place—we've got answers to all your rapid testing questions.
続きを読む »